3 Factor Indexing’s Ionis Pharmaceuticals IONS Stock Holding History

3 Factor Indexing’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$159	Hold	2	–	–	﹤0.01%	328
2026 Q1	$151	Buy	+2	New	+$158	﹤0.01%	334

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

3 Factor Indexing's IONS Position: Q2 2026 in Review

3 Factor Indexing held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 2 shares worth $159. The position accounts for ﹤0.01% of the portfolio, ranked #328.

3 Factor Indexing first reported a position in IONS in Q1 2026 and has held it in 2 quarters since. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

3 Factor Indexing held 2 shares of Ionis Pharmaceuticals worth $159 as of Q2 2026.
3 Factor Indexing left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of 3 Factor Indexing's portfolio in Q2 2026, its #328 holding.
3 Factor Indexing first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.